Bgi Biotechnology Wuhan Co L T D

FDA Filings

This page includes the latest FDA filings for Bgi Biotechnology Wuhan Co L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

• Registration Number: 0
• FEI Number: 0
• Name: Charles Bao
• Owner & Operator: BGI Biotechnology (Wuhan) Co., Ltd
• Contact Address: Building B2, Zone B/C/D, Wuhan National NO.666 Gaoxin Avenue, East Lake High-tec; Wuhan CN-42 Hubei 430075 CN
• Official Correspondent:
  • Zhengyu Cheng
  • 86-275-9273300-x
• US Agent:
  • Charles Bao
  • BGI Americas Corp.
  • 908 9224787
  • 617 5002742
  • charles.bao@bgi.com
• Importing Logistics Registration:
  • Importer: BGI Americas Corporation
  • Address: 1 Broadway 14th FL ; Cambridge, MA 02142 UNITED STATES
  • Email Address: bgia_accounting@bgi.com
  • Phone: 1 617 5002741
  • FAX: 1 617 5002742
• Registration Status: 5
• Initial Importer: N
• Registration Expiration: 2020-04-25
• Registration Address: 1 Broadway 14th FL ; Cambridge, MA 02142 US
• Establishment Type: Manufacture Medical Device

FDA Filings

Device Company	Device	Date
QJR Charles Bao [BGI Biotechnology (Wuhan) Co., Ltd]	Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV	2020-04-05